Predictors of 6-month clinical change in primary progressive aphasia following language therapy and transcranial magnetic stimulation

Clicks: 13
ID: 332888
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #172 of 196 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 196 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by progressive language impairment. Available treatments and information on factors associated with clinical change and treatment response remain limited. This study is a post-hoc analysis of a randomized controlled trial and aimed to identify baseline demographic, cognitive, and neuroimaging factors associated with clinical change in a subanalysis of a double-blind, randomized, parallel clinical trial of transcranial magnetic stimulation (TMS) and language therapy in PPA. Fifty-seven patients diagnosed with PPA received six months of lexical retrieval treatment, 40 with active TMS and 17 with sham TMS. All participants underwent comprehensive cognitive and language assessments before treatment and were evaluated using the Mini Linguistic State Examination (MLSE), naming task, words per minute, the Interview for Deterioration in Daily Living Activities in Dementia (IDDD), the Neuropsychiatric Inventory (NPI), and fluorodeoxyglucose positron emission tomography (FDG-PET) scans before and after treatment. Predictors of clinical change were analyzed using least absolute shrinkage and selection operator (LASSO) and Elastic Net regression models, and unsupervised k-means clustering was applied to identify response profiles. Models for MLSE (LASSO: R2=0.52; Elastic Net: R2=0.57), naming (LASSO: R2=0.42; Elastic Net: R2=0.41), IDDD (LASSO: R2=0.46; Elastic Net: R2=0.58), and NPI (LASSO: R2=0.81; Elastic Net: R2=0.77) demonstrated good predictive accuracy. TMS treatment consistently emerged as the strongest predictor of clinical improvement across all outcomes. Higher metabolism in several brain regions (left hippocampus, posterior cingulate, and orbitofrontal cortex) predicted greater clinical improvement. Cluster analysis identified two subgroups: responders and non-responders, with 77.5% of patients receiving active TMS in the responder cluster, and 82.4% of the sham group in the non-responder cluster. Among patients receiving active TMS, a positive effect was associated with the non-fluent and semantic variants and with better cognitive performance in non-language domains. In conclusion, TMS treatment emerged as the main factor associated with clinical improvement on cognitive-linguistic and functional measures. Better cognitive performance and preserved brain metabolism in key regions were linked to more favorable clinical outcomes. These findings underscore the potential of TMS in combination with language therapy, and pave the way for precision medicine approaches in PPA, emphasizing the need to identify individual profiles that predict optimal treatment response.
Reference Key
openalex_W7222933301 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lucía Fernández‐Romero, Cristina Delgado‐Alonso, Stephanie M. Grasso, María Nieves Cabrera‐Martín, Paloma Balugo, Adela Fraile-Pereda, Paz Suárez‐Coalla, Yadhira Barroso, Silvia Oliver‐Mas, Jorge Matías‐Guiu, Javier Olazarán, María Díez‐Cirarda
Are you one of these authors? Claim your profile
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag398
URL
https://doi.org/10.1093/braincomms/fcag398
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.